The Motley Fool

Key Data Points

Primary metrics and data points about ImmunoGen.
Current Price: $9.02
Prev Close: $9.03
Open: $9.00
Bid: $8.70
Ask: $9.24
Day's Range: $8.82 - $9.09
52wk Range: $5.34 - $13.78
Volume: 850,061
Avg Vol 1,349,130
Market Cap: $777M
P/E (ttm): -13.89
EPS (ttm): ($0.65)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for ImmunoGen.

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

IMGN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about ImmunoGen.
CAPS Rating 4 out of 5
334 Outperform
23 Underperform
CAPS All Stars
81 Outperform
4 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dan Junius, CEO

80% Approve

Based on 6 Ratings

More Details for ImmunoGenJobs

Powered by

More Details about ImmunoGen

Primary metrics and data points about ImmunoGen.